Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Oligodendroglioma Stories

2014-04-09 12:31:14

Three molecularly defined clusters could alter practice; 1 closely resembles deadly glioblastoma Comprehensive genomic analysis of low-grade brain tumors sorts them into three categories, one of which has the molecular hallmarks and shortened survival of glioblastoma multiforme, the most lethal of brain tumors, researchers reported at the American Association for Cancer Research Annual Meeting 2014. "The immediate clinical implication is that a group of patients with tumors previously...

2014-02-04 11:02:59

Presence of IDH1 mutation determines best treatment for malignant astrocytomas Astrocytomas are the most common malignant brain tumors. While most patients' tumors prove to be quite aggressive, outcomes overall can vary widely, with some patients surviving for many years. Now a new study has found that malignant astrocytoma patients whose tumors carry a specific genetic mutation benefit greatly from surgical removal of the largest possible amount of tumor. Preliminary results of the study...

2013-11-23 23:02:03

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Matt Englander for his determination to embrace life despite his battle with brain cancer. New York, NY (PRWEB) November 23, 2013 Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Matt Englander for his will to live a full life despite his battle with brain cancer. According to a November 13, 2013 article published by ABC News titled...

Genetic Pathway Could Be New Target For Pediatric Tumor Treatment
2013-11-07 11:27:12

redOrbit Staff & Wire Reports - Your Universe Online Low-grade gliomas – a type of pediatric brain tumor that is difficult to care for medically – could potentially be treated using a known genetic pathway, according to new research published in Thursday’s edition of the journal Neuro-Oncology. In laboratory studies, Dr. Fausto Rodriguez, assistant professor of pathology and oncology at Johns Hopkins, and colleagues reported that the mammalian target of the rapamycin (mTOR)...

2013-05-01 15:32:07

A type of low-grade but sometimes lethal brain tumor in children has been found in many cases to contain an unusual mutation that may help to classify, diagnose and guide the treatment of the tumors, report scientists at Dana-Farber Cancer Institute. The researchers led a study of pediatric low-grade gliomas, samples of which were collected through an international consortium organized by brain tumor specialists at Dana-Farber/Children's Hospital Cancer Center. Their findings are being...

2013-03-22 23:04:18

Louis and Phyllis Jacobs Honored for Commitment to Brain Tumor Patients and the ABTA Chicago, IL (PRWEB) March 22, 2013 The American Brain Tumor Association (ABTA) has named Louis and Phyllis Jacobs as the recipients of the 2013 Joel A. Gingras, Jr. Award. For the past 14 years, the Jacobs have supported brain tumor patients and families in their community, as well as supported the ABTA´s brain tumor research funding initiatives. The Joel A. Gingras, Jr. Award is given annually to an...

2012-11-15 12:27:35

VANCOUVER, British Columbia, Nov. 15, 2012 /PRNewswire/ -- Del Mar Pharmaceuticals (BC) Ltd. ("DelMar Pharma") today announced that the Company will present two scientific posters at the Society for Neuro-Oncology (SNO) 17(th) Annual Scientific Meeting, which is being held in Washington, DC November 15-18, 2012. On Friday November 16(th), DelMar will present a poster entitled, "VAL-083, Novel N7 Alkylating Agent, Surpasses Temozolomide Activity and Inhibits Cancer Stem Cells Providing a...

New Discovery May Help Doctors Slow Progression And Recurrence Of Brain Cancer
2012-10-22 20:57:41

Scientists have long believed that glioblastoma multiforme (GBM), the most aggressive type of primary brain tumor, begins in glial cells that make up supportive tissue in the brain or in neural stem cells. In a paper published October 18 in Science Express, however, researchers at the Salk Institute for Biological Studies have found that the tumors can originate from other types of differentiated cells in the nervous system, including cortical neurons. GBM is one of the most devastating...

2012-05-17 12:09:10

-The system doctors use to classify patients' malignant brain tumors is outdated. -Researchers have revised the system to accommodate treatment advances and molecular markers. -The new system will be validated in future clinical trials for malignant gliomas. Radiation oncology researchers have revised the system used by doctors since the 1990s to determine the prognosis of people with glioblastoma, which is the most devastating of malignant brain tumors. The outdated system was...

2012-03-22 22:45:29

Researchers at Winship Cancer Institute have developed a technique for detecting an "oncometabolite", a chemical produced by some brain tumors´ warped metabolism, via non-invasive imaging. Their approach could allow doctors to know not only that a brain tumor is there, but also that it carries a particular genetic mutation. The researchers´ technique uses magnetic resonance spectroscopy (MRS) to measure a chemical, 2-hydroxyglutarate, which is scarce in normal tissues....